Enforcement News: Biotech Company and Its CEO Charged With Fraud Concerning Blood Testing Device for COVID-19
- Dec 21 2020
In prior posts, we examined enforcement actions brought by the Securities and Exchange Commission (“SEC” or “Commission”) against those who seek to benefit from the COVID-19 pandemic (e.g., here, here …